Get started
Author

Jiří Sagan

Observed names: J Sagan, Jiri Sagan, Sagan J
ORCID: 0000-0003-0684-5138
Observed ORCID: 0000-0003-0684-5138
OpenAlex ID: A5090788198
Therapeutic monitoring of serum concentrations of acyclovir and its metabolite 9-(carboxymethoxymethyl) guanine in routine clinical practice
2022 · Ivana Kacirova, Romana Urinovska, et al. · Biomedicine & Pharmacotherapy · 19
PDF
Determination of acyclovir and its metabolite 9‐carboxymethoxymethylguanide in human serum by ultra‐high‐performance liquid chromatography‐tandem mass spectrometry
2021 · Romana Urinovska, Ivana Kacirova, et al. · Journal of Separation Science · 11
A safety comparison of heparin and argatroban anticoagulation in veno‐venous extracorporeal membrane oxygenation with a focus on bleeding
2024 · Filip Burša, Jan Máca, et al. · Transfusion Medicine · 6
PDF
Convalescent anti-SARS-CoV-2 plasma for the treatment of patients with COVID-19: a retrospective study RESCOVID-19
2024 · Miloš Bohoněk, Jan Máca, et al. · Virology Journal · 4
PDF
The importance of therapeutic drug monitoring in acyclovir dosage optimization
2023 · Ivana Kacířová, Romana Uřinovská, et al. · Klinická farmakologie a farmacie · 3
PDF
Activated Partial Thromboplastin Time and Anti-IIa Monitoring in Argatroban Anticoagulation in COVID-19 Patients on Venovenous Extracorporeal Membrane Oxygenation
2025 · Filip Burša, Michal Frelich, et al. · Clinical and Applied Thrombosis/Hemostasis · 2
Protective mechanical ventilation controlled by the real-time mechanical power measurement
2025 · Filip Burša, Michal Frelich, et al. · Journal of Clinical Monitoring and Computing · 1
PDF
Alveolar-arterial oxygen difference in intensive care
2025 · M Kutěj, F Haiduk, et al. · Anesteziologie a intenzivní medicína · 1
Time in Therapeutic Range of Unfractionated Heparin-Based Therapy in Critically Ill Patients with COVID-19 Pneumonia
2024 · Tereza Romanová, Filip Burša, et al. · Therapeutics and Clinical Risk Management · 1
Report on the program of the use of convalescent plasma in the treatment of patients with COVID-19 in the Czech Republic and the results of the national multicentre study RESCOVID-19
2023 · Miloš Bohoněk, David Řezáč, et al. · Transfuze a hematologie dnes · 1
[Neuroleptic malignant syndrome - unexpected complication in a COVID-19 patient].
2022 · Jiří Sagan, Martin Hýža, et al. · PubMed · 1
[Severe course of influenza B complicated by rhabdomyolysis and acute respiratory failure resulting in death].
2018 · Jiří Sagan, Petr Širůček, et al. · PubMed · 1
[Low prevalence of viremia in COVID-19: Clinical implications].
2026 · Jiří Sagan, Martin Kutěj, et al. · PubMed
Convalescent Plasma—What is its Perspective in the Treatment of COVID-19 and Other Viral Diseases? A Narrative Review
2025 · Jiří Sagan, Martin Kutěj, et al. · Bratislavské lekárske listy/Bratislava medical journal
PDF
Protective mechanical ventilation controlled by the real-time mechanical energy measurement
2025 · Filip Burša, Michal Frelich, et al. · Research Square
PDF
Neuroleptic malignant syndrome in a patient with COVID-19 and the possible role of SARS-CoV-2 in its manifestation: case report and overview of published cases
2025 · Tomas Skront, Jiri Sagan, et al. · BMC Psychiatry
PDF
Haemolytic-uremic syndrome associated with infection
2024 · Jiří Sagan, Martina Bielaszewska, et al. · Transfuze a hematologie dnes
Role of Alveolar-Arterial Difference in Estimation of Extravascular Lung Water in COVID-19-Related ARDS
2024 · Martin Kutej, Jiri Sagan, et al. · Respiratory Care
PDF
[Drug repositioning - antibiotics as cytostatics].
2020 · Jiří Sagan · PubMed
Works count: 20
Citation count: 51
H-index: 4
I10-index: 2
Year
Topic
Type